UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000018606 |
|---|---|
| Receipt number | R000021531 |
| Scientific Title | Phase I study of Ramucirumab and Irinotecan for metastatic gastric cancer previously treated with Fluoropyrimidine with/without Platinum and Taxane. |
| Date of disclosure of the study information | 2015/08/11 |
| Last modified on | 2019/02/09 09:14:42 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/08/08 21:53:46 | ||
| 2 | Update | 2015/08/11 13:31:06 | Acronym |
|
| 3 | Update | 2015/08/11 13:41:30 | Interventions/Control_1 Interventions/Control_1 |
|
| 4 | Update | 2015/08/11 13:48:54 | Primary outcomes Primary outcomes |
|
| 5 | Update | 2015/08/11 13:50:19 | Interventions/Control_1 Interventions/Control_1 |
|
| 6 | Update | 2017/06/17 10:44:38 | Recruitment status |
|
| 7 | Update | 2019/02/09 09:13:05 | Name of primary person or sponsor Organization |
|
| 8 | Update | 2019/02/09 09:14:42 | Recruitment status Publication of results |
